Sino Biopharm Shares Sink 14% in Hong Kong After Earnings Shock

(Bloomberg) -- Chinese vaccine maker Sino Biopharmaceutical Ltd. fell as much as 14% in Hong Kong to its lowest level since April, after its third-quarter earnings missed expectations.